SCHEMBL14797147

SCHEMBL14797147

Cc1cc(-c2nc3cnc(Oc4ccccc4)nc3o2)cc(C)c1OCC(=O)OC(C)(C)C

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 1/20 0.67
MAPT P10636 4/20 0.37
CYP2C9 P11712 4/20 0.37
CYP2C19 P33261 4/20 0.37
HPGD P15428 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
LMNA P02545 2/20 0.37
POLB P06746 1/20 0.37
GPR119 Q8TDV5 1/20 0.36
HPGDS O60760 3/20 0.35
DHODH Q02127 1/20 0.35
ALDH1A1 P00352 9/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
KDM4E B2RXH2 2/20 0.34
HTT P42858 1/20 0.34
CYP1A2 P05177 7/20 0.34
TSHR P16473 3/20 0.34
MAPK1 P28482 2/20 0.34
CETP P11597 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2223368 0.89 S1PR1 (0.83) S1PR1MAPTCYP2C9CYP2C19LMNA
SCHEMBL2223316 0.82 S1PR1 (0.75) S1PR1MAPTPOLBALDH1A1KMT2A
SCHEMBL14797044 0.82 S1PR1 (0.52) S1PR1MAPTCYP2C9CYP2C19HPGD
SCHEMBL14797145 0.82 S1PR1 (0.77) S1PR1ALDH1A1MEN1KMT2AKDM4E
SCHEMBL2221025 0.82 S1PR1 (0.83) S1PR1MAPTHPGDNPSR1POLB
SCHEMBL14797011 0.81 S1PR1 (0.82) S1PR1MAPTCYP2C9CYP2C19HPGD
SCHEMBL2222826 0.81 S1PR1 (0.73) S1PR1MAPTCYP2C9CYP2C19HPGD
SCHEMBL2222062 0.81 S1PR1 (0.82) S1PR1MAPTNPSR1ALDH1A1MEN1
SCHEMBL2228763 0.81 S1PR1 (0.64) S1PR1CYP2C9CYP2C19HPGDALDH1A1
SCHEMBL2222592 0.80 S1PR1 (0.81) S1PR1DHODHCETP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8846692-B2 Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring SANOFI (FR) 2014-09-30 US disclosed
US-20130079358-A1 CARBOXYLIC ACID DERIVATIVES HAVING A 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE RING SANOFI (FR) 2013-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130079358-A1 CARBOXYLIC ACID DERIVATIVES HAVING A 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE RING OXGR1, EDNRA, EDF1 S1PR1 129/4885MAPT 4394/4885CYP2C9 1076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.